PAPER Skene JP, Cleveland DW
SEARCH RESULTS
331159 RESULTS
John Cirrito on Composition of isolated synaptic boutons reveals the amounts of vesicle trafficking proteins.
COMMENT Clearly, this is an amazing paper. The detail of the number and spatial location of proteins is remarkable. I appreciate their discussion of what the copy number of proteins may mean functionally; to compensate for a relatively small amount of endocytic m
PAPER Tsao N, Hsu HP, Wu CM, Liu CC, Lei HY
Tumour necrosis factor-alpha causes an increase in blood-brain barrier permeability during sepsis.
J Med Microbiol. 2001 Sep;50(9):812-21. PubMed: 11549183PAPER Tan J, Town T, Paris D, Placzek A, Parker T, Crawford F, Yu H, Humphrey J, Mullan M
Activation of microglial cells by the CD40 pathway: relevance to multiple sclerosis.
J Neuroimmunol. 1999 Jun 1;97(1-2):77-85. PubMed: 10408982Joe Yates
United States
PAPER Clayton JA, Collins FS
Policy: NIH to balance sex in cell and animal studies.
Nature. 2014 May 15;509(7500):282-3. PubMed: 24834516Esther Stroo
Groningen, Netherlands
PAPER Kim S, Lee Y, Cho J
Korean red ginseng extract exhibits neuroprotective effects through inhibition of apoptotic cell death.
Biol Pharm Bull. 2014;37(6):938-46. PubMed: 24882407PAPER Lasagna-Reeves CA, Sengupta U, Castillo-Carranza D, Gerson JE, Guerrero-Munoz M, Troncoso JC, Jackson GR, Kayed R
The formation of tau pore-like structures is prevalent and cell specific: possible implications for the disease phenotypes.
Acta Neuropathol Commun. 2014 May 29;2:56. PubMed: 24887264PAPER Ouzounoglou E, Kalamatianos D, Emmanouilidou E, Xilouri M, Stefanis L, Vekrellis K, Manolakos ES
In silico modeling of the effects of alpha-synuclein oligomerization on dopaminergic neuronal homeostasis.
BMC Syst Biol. 2014 May 13;8:54. PubMed: 24885905PAPER Overk CR, Cartier A, Shaked G, Rockenstein E, Ubhi K, Spencer B, Price DL, Patrick C, Desplats P, Masliah E
Hippocampal neuronal cells that accumulate α-synuclein fragments are more vulnerable to Aβ oligomer toxicity via mGluR5- implications for dementia with Lewy bodies.
Mol Neurodegener. 2014 May 19;9:18. PubMed: 24885390PAPER Lai Y, Kim S, Varkey J, Lou X, Song JK, Diao J, Langen R, Shin YK
Nonaggregated α-synuclein influences SNARE-dependent vesicle docking via membrane binding.
Biochemistry. 2014 Jun 24;53(24):3889-96. Epub 2014 Jun 13 PubMed: 24884175PAPER Knight AL, Yan X, Hamamichi S, Ajjuri RR, Mazzulli JR, Zhang MW, Daigle JG, Zhang S, Borom AR, Roberts LR, Lee SK, DeLeon SM, Viollet-Djelassi C, Krainc D, O'Donnell JM, Caldwell KA, Caldwell GA
The glycolytic enzyme, GPI, is a functionally conserved modifier of dopaminergic neurodegeneration in Parkinson's models.
Cell Metab. 2014 Jul 1;20(1):145-57. Epub 2014 May 29 PubMed: 24882066PAPER Ayers JI, Xu G, Pletnikova O, Troncoso JC, Hart PJ, Borchelt DR
Conformational specificity of the C4F6 SOD1 antibody; low frequency of reactivity in sporadic ALS cases.
Acta Neuropathol Commun. 2014 May 14;2:55. PubMed: 24887207PAPER Mancuso R, Del Valle J, Morell M, Pallás M, Osta R, Navarro X
Lack of synergistic effect of resveratrol and sigma-1 receptor agonist (PRE-084) in SOD1G⁹³A ALS mice: overlapping effects or limited therapeutic opportunity?
Orphanet J Rare Dis. 2014 May 21;9:78. PubMed: 24885036Current Filters
No filters selected